🇺🇸 FDA
Patent

US 9969754

Compounds for treating spinal muscular atrophy

granted A61PA61P21/00A61P21/02

Quick answer

US patent 9969754 (Compounds for treating spinal muscular atrophy) held by PTC THERAPEUTICS, INC. expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61P, A61P21/00, A61P21/02, A61P25/28